-+ 0.00%
-+ 0.00%
-+ 0.00%

Kangzhi Pharmaceutical (300086.SZ) was filed by the China Securities Regulatory Commission for suspected information disclosure violations

Zhitongcaijing·09/18/2026 11:33:08
Listen to the news

According to Zhitong Finance App, Kangzhi Pharmaceutical (300086.SZ) issued an announcement. Today, the company received the “Notice of Case Filing” (ID: Securities Regulatory Commission No. 0292026003) issued by the China Securities Regulatory Commission (hereinafter referred to as the “China Securities Regulatory Commission”). The China Securities Regulatory Commission decided to file a case against the company in accordance with laws and regulations such as the “Securities Law of the People's Republic of China” and “Administrative Penalty Law of the People's Republic of China” due to the company's suspected illegal disclosure of information.